CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | HURWITZ EDWARD Director | Grant or award · Stock option (right to buy) | +35,152 | 35,152 | ||
| 2025-05-30 | HURWITZ EDWARD Director | Grant or award · Stock option (right to buy) | +35,000 | 35,000 | ||
| 2024-05-22 | HURWITZ EDWARD Director | Grant or award · Stock option (right to buy) | +25,133 | 25,133 | ||
| 2023-05-24 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +24,900 | 24,900 | ||
| 2022-06-03 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +19,596 | 19,596 | ||
| 2021-05-26 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +19,596 | 19,596 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +4,614,943 | 4,614,943 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +245,279 | 245,279 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +91,081 | 91,081 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −13,980,992 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −743,076 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −275,932 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −1,326,313 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −70,492 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −26,176 | 0 | ||
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +1,326,313 | $2.81 | $3.7M | 1,326,313 |
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +70,492 | $2.81 | $198K | 70,492 |
| 2020-08-07 | HURWITZ EDWARD Director | Purchase · Series B Preferred Stock | +26,176 | $2.81 | $74K | 26,176 |
| 2020-07-31 | HURWITZ EDWARD Director | Purchase · Series A Preferred Stock | +4,893,347 | $1.00 | $4.9M | 13,980,992 |
| 2020-07-31 | HURWITZ EDWARD Director | Purchase · Series A Preferred Stock | +260,077 | $1.00 | $260K | 743,076 |
Page 1 of 2 · 21 trades